Utah Retirement Systems’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.05M | Sell |
16,302
-281
| -2% | -$35.3K | 0.02% | 543 |
|
|
2025
Q1 | $1.83M | Hold |
16,583
| – | – | 0.02% | 569 |
|
|
2024
Q4 | $2.26M | Buy |
16,583
+100
| +0.6% | +$13.7K | 0.02% | 534 |
|
|
2024
Q3 | $1.9M | Hold |
16,483
| – | – | 0.02% | 575 |
|
|
2024
Q2 | $2.27M | Sell |
16,483
-200
| -1% | -$27.5K | 0.03% | 508 |
|
|
2024
Q1 | $2.3M | Hold |
16,683
| – | – | 0.03% | 526 |
|
|
2023
Q4 | $2.2M | Hold |
16,683
| – | – | 0.03% | 521 |
|
|
2023
Q3 | $1.88M | Buy |
16,683
+100
| +0.6% | +$11.3K | 0.03% | 538 |
|
|
2023
Q2 | $1.56M | Sell |
16,583
-200
| -1% | -$18.9K | 0.02% | 612 |
|
|
2023
Q1 | $1.7M | Hold |
16,783
| – | – | 0.02% | 583 |
|
|
2022
Q4 | $2M | Sell |
16,783
-200
| -1% | -$23.9K | 0.03% | 488 |
|
|
2022
Q3 | $1.8M | Buy |
16,983
+300
| +2% | +$31.9K | 0.03% | 512 |
|
|
2022
Q2 | $1.63M | Hold |
16,683
| – | – | 0.03% | 553 |
|
|
2022
Q1 | $1.56M | Sell |
16,683
-300
| -2% | -$28.1K | 0.02% | 617 |
|
|
2021
Q4 | $1.45M | Hold |
16,983
| – | – | 0.02% | 677 |
|
|
2021
Q3 | $1.63M | Sell |
16,983
-800
| -4% | -$76.7K | 0.02% | 630 |
|
|
2021
Q2 | $1.73M | Buy |
17,783
+100
| +0.6% | +$9.73K | 0.02% | 636 |
|
|
2021
Q1 | $1.72M | Sell |
17,683
-800
| -4% | -$77.8K | 0.02% | 614 |
|
|
2020
Q4 | $1.77M | Buy |
18,483
+800
| +5% | +$76.7K | 0.03% | 567 |
|
|
2020
Q3 | $1.7M | Buy |
17,683
+200
| +1% | +$19.2K | 0.03% | 526 |
|
|
2020
Q2 | $2.13M | Buy |
17,483
+300
| +2% | +$36.6K | 0.04% | 415 |
|
|
2020
Q1 | $1.49M | Hold |
17,183
| – | – | 0.03% | 463 |
|
|
2019
Q4 | $1.85M | Hold |
17,183
| – | – | 0.03% | 521 |
|
|
2019
Q3 | $1.55M | Buy |
17,183
+100
| +0.6% | +$9.01K | 0.03% | 558 |
|
|
2019
Q2 | $1.44M | Buy |
17,083
+102
| +0.6% | +$8.61K | 0.03% | 594 |
|
|
2019
Q1 | $1.5M | Buy |
16,981
+381
| +2% | +$33.6K | 0.03% | 558 |
|
|
2018
Q4 | $1.19M | Buy |
16,600
+100
| +0.6% | +$7.14K | 0.03% | 583 |
|
|
2018
Q3 | $2.03M | Hold |
16,500
| – | – | 0.04% | 456 |
|
|
2018
Q2 | $1.62M | Hold |
16,500
| – | – | 0.03% | 527 |
|
|
2018
Q1 | $1.37M | Buy |
16,500
+200
| +1% | +$16.6K | 0.03% | 576 |
|
|
2017
Q4 | $1.27M | Buy |
16,300
+300
| +2% | +$23.3K | 0.03% | 621 |
|
|
2017
Q3 | $980K | Hold |
16,000
| – | – | 0.02% | 683 |
|
|
2017
Q2 | $736K | Buy |
16,000
+300
| +2% | +$13.8K | 0.02% | 799 |
|
|
2017
Q1 | $680K | Hold |
15,700
| – | – | 0.02% | 794 |
|
|
2016
Q4 | $608K | Buy |
15,700
+100
| +0.6% | +$3.87K | 0.02% | 819 |
|
|
2016
Q3 | $790K | Hold |
15,600
| – | – | 0.02% | 720 |
|
|
2016
Q2 | $709K | Buy |
+15,600
| New | +$709K | 0.02% | 750 |
|